Advanced search

Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.

(1998) ACTA NEUROLOGICA BELGICA. 98(4). p.332-341
Author

Citation

Please use this url to cite or link to this publication:

Chicago
LALOUX, P, A VAKAET, G MONSEU, J JACQUY, P BOURGEOIS, and C VAN DER LINDEN. 1998. “Subcutaneous Sumatriptan Compared with Usual Acute Treatments for Migraine: Clinical and Pharmacoeconomic Evaluation.” Acta Neurologica Belgica 98 (4): 332–341.
APA
LALOUX, P., VAKAET, A., MONSEU, G., JACQUY, J., BOURGEOIS, P., & VAN DER LINDEN, C. (1998). Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation. ACTA NEUROLOGICA BELGICA, 98(4), 332–341.
Vancouver
1.
LALOUX P, VAKAET A, MONSEU G, JACQUY J, BOURGEOIS P, VAN DER LINDEN C. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation. ACTA NEUROLOGICA BELGICA. 1998;98(4):332–41.
MLA
LALOUX, P, A VAKAET, G MONSEU, et al. “Subcutaneous Sumatriptan Compared with Usual Acute Treatments for Migraine: Clinical and Pharmacoeconomic Evaluation.” ACTA NEUROLOGICA BELGICA 98.4 (1998): 332–341. Print.
@article{174095,
  author       = {LALOUX, P and VAKAET, A and MONSEU, G and JACQUY, J and BOURGEOIS, P and VAN DER LINDEN, C},
  issn         = {0300-9009},
  journal      = {ACTA NEUROLOGICA BELGICA},
  language     = {eng},
  number       = {4},
  pages        = {332--341},
  title        = {Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.},
  volume       = {98},
  year         = {1998},
}

Web of Science
Times cited: